Can we modulate the gut microbiome to enhance DMARD efficacy in rheumatoid arthritis?
作者信息
Blank Rebecca B, Nayak Renuka R, Scher Jose U
机构信息
Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, USA.
Rheumatology Division, Department of Medicine, University of California, San Francisco, CA, USA.
出版信息
Semin Arthritis Rheum. 2025 Feb;70S:152583. doi: 10.1016/j.semarthrit.2024.152583. Epub 2024 Nov 10.
Abstract
摘要
相似文献
1
Can we modulate the gut microbiome to enhance DMARD efficacy in rheumatoid arthritis?
Semin Arthritis Rheum. 2025 Feb;70S:152583. doi: 10.1016/j.semarthrit.2024.152583. Epub 2024 Nov 10.
2
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
Cochrane Database Syst Rev. 2016 May 13;2016(5):CD012183. doi: 10.1002/14651858.CD012183.
3
Role of the intestinal flora-immunity axis in the pathogenesis of rheumatoid arthritis-mechanisms regulating short-chain fatty acids and Th17/Treg homeostasis.
Mol Biol Rep. 2025 Jun 21;52(1):617. doi: 10.1007/s11033-025-10714-w.
4
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
5
Immunomodulatory properties of the gut microbiome: diagnostic and therapeutic potential for rheumatoid arthritis.
Clin Exp Med. 2025 Jul 1;25(1):226. doi: 10.1007/s10238-025-01777-x.
6
The interplay between gut microbiome and physical exercise in athletes.
Curr Opin Clin Nutr Metab Care. 2024 Sep 1;27(5):428-433. doi: 10.1097/MCO.0000000000001056. Epub 2024 Jul 18.
7
Medication adherence in rheumatoid arthritis: implications for cardiovascular disease risk and strategies to address in U.S. veterans.
Expert Rev Pharmacoecon Outcomes Res. 2025 Apr;25(4):473-485. doi: 10.1080/14737167.2025.2451141. Epub 2025 Jan 20.
8
HDAC/NF-κB signaling pathway mediates gut microbiota dysbiosis in rheumatoid arthritis: Intervention mechanisms of Fengshining decoction.
Phytomedicine. 2025 Sep;145:156976. doi: 10.1016/j.phymed.2025.156976. Epub 2025 Jun 16.
9
Genome-scale metabolic modelling of human gut microbes to inform rational community design.
Gut Microbes. 2025 Dec;17(1):2534673. doi: 10.1080/19490976.2025.2534673. Epub 2025 Jul 20.
10
Exploring the gut microbiome's influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies.
World J Gastrointest Pharmacol Ther. 2025 Jun 5;16(2):105375. doi: 10.4292/wjgpt.v16.i2.105375.
本文引用的文献
1
SIMMER employs similarity algorithms to accurately identify human gut microbiome species and enzymes capable of known chemical transformations.
Elife. 2023 Jun 12;12:e82401. doi: 10.7554/eLife.82401.
2
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis.
Sci Transl Med. 2023 Feb 22;15(684):eabq8476. doi: 10.1126/scitranslmed.abq8476.
3
participates in the therapeutic effect of methotrexate on arthritis through metabolite regulation.
Front Microbiol. 2022 Dec 15;13:1015130. doi: 10.3389/fmicb.2022.1015130. eCollection 2022.
4
Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial.
JAMA Netw Open. 2022 Dec 1;5(12):e2244912. doi: 10.1001/jamanetworkopen.2022.44912.
5
Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of .
Sci Transl Med. 2022 Oct 26;14(668):eabn5166. doi: 10.1126/scitranslmed.abn5166.
6
Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis.
Sci Adv. 2022 Feb 11;8(6):eabm1511. doi: 10.1126/sciadv.abm1511.
7
Gut Microbiota-Medication Interaction in Rheumatic Diseases.
Front Immunol. 2021 Dec 3;12:796865. doi: 10.3389/fimmu.2021.796865. eCollection 2021.
8
The gut-joint axis in rheumatoid arthritis.
Nat Rev Rheumatol. 2021 Apr;17(4):224-237. doi: 10.1038/s41584-021-00585-3. Epub 2021 Mar 5.
9
Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation.
Cell Host Microbe. 2021 Mar 10;29(3):362-377.e11. doi: 10.1016/j.chom.2020.12.008. Epub 2021 Jan 12.
10
The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis.
Arthritis Rheumatol. 2021 Jun;73(6):931-942. doi: 10.1002/art.41622. Epub 2021 May 2.
Zotero 插件